Substituted pyrroline kinase inhibitors
US7781450B2 · kind B2 · utility
1Cited by
6References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2009 |
| Grant date | Aug 24, 2010 |
| Priority date | — |
| Expiry date | Mar 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.